SCI
ABBV icon

Seneca Capital Investments’s AbbVie ABBV Stock Holding History

Seneca Capital Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-152,500
Closed -$8.3M – 3
2015
Q3 		$8.3M Buy
+152,500
New +$9.93M 2.98% 10

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Seneca Capital Investments's ABBV Position: Q4 2015 in Review

Seneca Capital Investments sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 152,500 shares — an estimated $8.3M sold.

Seneca Capital Investments first reported a position in ABBV in Q3 2015 and held it in 1 quarter. The position peaked at $8.3M in Q3 2015. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Seneca Capital Investments reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Seneca Capital Investments sold 152,500 AbbVie shares in Q4 2015, an estimated $8.3M.
  • Seneca Capital Investments first reported a position in AbbVie in Q3 2015 and held it in 1 quarter.
  • Seneca Capital Investments's AbbVie position peaked at $8.3M in Q3 2015.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Seneca Capital Investments's 13F filing for Q4 2015, filed 16 Feb 2016.